Adagio Therapeutics has granted an exclusive licence to the company to manufacture and commercialise an antibody treatment based on ADG20 for India and select emerging markets.
from Top India News- News18.com https://ift.tt/3eXZuzW
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment